The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Harris Robert Paul since year 2005.
The trader's CIK number is 1537250.
At the time of this reporting, Harris Robert Paul is the Director of Aralez Pharmaceuticals Inc. .
(stock ticker symbol ARLZ).
See this page for all insider trading activities at Aralez Pharmaceuticals Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2016-11-29||ARLZ||Aralez Pharmaceuticals Inc.||Option Ex||104,778||3.92||410,729|
|2016-11-28||ARLZ||Aralez Pharmaceuticals Inc.||Option Ex||20,000||3.92||78,400|
|2016-11-29||ARLZ||Aralez Pharmaceuticals Inc.||Sale||104,778||4.99||523,156|
|2016-11-28||ARLZ||Aralez Pharmaceuticals Inc.||Sale||20,000||4.65||93,000|
|2016-09-15||ARLZ||Aralez Pharmaceuticals Inc.||Sale||150,000||5.82||873,150|
|2013-02-27||TBUFF||Stellar Pharmaceuticals Inc||Buy||625,000||.40||250,000|
|2012-03-22||TBUFF||Stellar Pharmaceuticals Inc||Buy||1,100,000||.56||616,000|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Harris Robert Paul (Director of Aralez Pharmaceuticals Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.